Site search

Clear filter
3042 results for '' found
Commercial Rd Pharmacy
-37.84673533062191, 144.99314952700917
/
HealthSmart Pharmacy – VCCC
-37.79957798992024, 144.95647799817118
/
HealthSmart Pharmacy – Alfred Hospital
-37.846035350084826, 144.9821825981725
/
Peach Clinic – Melbourne Sexual Health Centre
-37.804736503419306, 144.96278752675127
/
PrEPMe Clinic – The Alfred Hospital Infectious Diseases Clinic
-37.84612432868019, 144.98218796390742
/
PrEPMe Clinic – Victorian Pride Centre
-37.86052519171993, 144.97628579791697
/
A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE III CLINICAL TRIAL TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF NXT007 PROPHYLAXIS VERSUS EMICIZUMAB PROPHYLAXIS IN PEOPLE W
A MULTICENTER, RANDOMIZED, OPEN-LABEL, PHASE III CLINICAL TRIAL TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF NXT007 PROPHYLAXIS VERSUS EMICIZUMAB PROPHYLAXIS IN PEOPLE W
/
A Phase 2a, Placebo-Controlled, Single-Blind, Dose Range Finding Study of Inhaled ALX1 in Adults with Bronchiectasis (NCT07731919)
A Phase 2a, Placebo-Controlled, Single-Blind, Dose Range Finding Study of Inhaled ALX1 in Adults with Bronchiectasis (NCT07731919)
/
Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis (NCT07203391)
Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis (NCT07203391)
/
A Randomised Controlled Study of Semaglutide Versus Placebo in Patients With Obesity and Atrial Fibrillation: The SEMOAF Trial (Trial Not Registered)
A Randomised Controlled Study of Semaglutide Versus Placebo in Patients With Obesity and Atrial Fibrillation: The SEMOAF Trial (Trial Not Registered)
/
2 3 4 5 6